3) COPD Exacerbation (LO2): (updated 10/25/22)
a. American Family Physician - “Chronic Obstructive Pulmonary Disease: Diagnosis and Management” April 1, 2017
https://www.aafp.org/dam/brand/aafp/pubs/afp/issues/2017/0401/p433.pdf
Cochrane - “Role of Mucolytics in the Treatment of Chronic Bronchitis or COPD” July 1, 2020;
https://www.aafp.org/dam/brand/aafp/pubs/afp/issues/2020/0701/p16.pdf
b. New England Journal of Medicine “The Asthma-COPD Overlap Syndrome” September 24, 2015;
http://www.nejm.org/doi/pdf/10.1056/NEJMra1411863
“Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very Severe COPD” July 2, 2020;
https://www.nejm.org/doi/pdf/10.1056/NEJMoa1916046?articleTools=true
“Update in Clinical Aspects of Chronic Obstructive Pulmonary Disease” September 26, 2019;
https://www.nejm.org/doi/pdf/10.1056/NEJMra1900500?articleTools=true
c. UptoDate - “Management of acute exacerbations of chronic obstructive pulmonary disease”- (REQUIRED READING)
d. Global Initiative for Chronic Obstructive Lung Disease (GOLD): 2020 Update-Power Point:
https://goldcopd.org/gold-teaching-slide-set/
“Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease”- 2020 Report;
https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf